The 1.54 kb cDNA for ancrod, a thrombin-like enzyme, was cloned from a AZAP cDNA library derived from the venom glands of Calloselasma (Agkistrodon) rhodostoma. The cDNA sequence reveals that ancrod is synthesized as a pre-zymogen of 258 amino acids, including a putative secretory peptide of 18 amino acids and a proposed zymogen peptide of 6 amino-acid residues. The amino-acid sequence of the predicted active form of the enzyme exhibits a high degree of sequence similarity to those of mammalian serine proteases (trypsin and pancreatic kallikrein) and other thrombin-like enzymes (batroxobin and
INTRODUCTION
Snake venoms affect blood coagulation and platelet functions in a complex manner [1] . The venom of the snake Calloselasma rhodostoma (formerly known as Agkistrodon rhodostoma) contains both platelet-activating and platelet-inhibitory components, a haemorrhagic protein and a thrombin-like enzyme [1] [2] [3] [4] [5] [6] [7] . Thrombin-like enzymes [8] [9] [10] are serine proteases, which belong to the trypsin family [11] . In contrast with thrombin, which converts fibrinogen to fibrin by removing fibrinopeptides A and B, a thrombin-like enzyme releases only fibrinopeptide A from fibrinogen [12, 13] . Parenteral administration of the enzyme causes the conversion of fibrin into a fibrin derivative that is rapidly degraded and eliminated through a fibrinolytic process in the bloodstream [12] . Ancrod is a highly active thrombin-like enzyme purified from the venom of Calloselasma rhodostoma [13] . Since ancrod has been commercially available for many years, numerous exploratory studies on its clinical application have been reported [14] . The results have indicated considerable potential value for this protein in the treatment of various thrombo-embolic states, and in the prevention of thrombosis. However, the molecular characteristics of ancrod have not been described. Previously, we have cloned and analysed the cDNA for a platelet-aggregation inhibitor and for a haemorrhagic protein that were derived from the venom-gland cDNA library of Calloselasma rhodostoma [15] . Here, we report the cloning and nucleotide-sequence analysis of the cDNA for ancrod, and the deduced amino-acid sequence.
MATERIALS AND METHODS
Isolation of cDNA clones for ancrod A set of cDNAs derived from a poly(A)+ RNA preparation of the venom glands of Calloselasma rhodostoma were cloned into the Uni-ZAPTMXR vector [16] by inserting the cDNAs into flavoxobin). Key amino-acid residues (His43, Asp88, Serl82 and Asp176) that are thought to be involved in the substrate cleavage and in the substrate-binding reaction are conserved. Ancrod contains 13 cysteine residues. Based on alignment with the amino-acid sequences of trypsin and batroxobin, six disulphide bridges can be predicted to be present in the ancrod protein. The existence of a free cysteine, which changes the common sequence surrounding the Ser182 active site from Gly-Asp-Ser-Gly-Gly-Pro to Cys-Asp-Ser-Gly-Gly-Pro, is unusual for a serine protease.
the EcoRI and XhoI sites of the Uni-ZAPTMXR phage DNA. For convenience, the Uni-ZAPTXR vector was excised in vivo to generate a pBluescript SK-phagemid cDNA library by cotransfecting the Uni-ZAPMXR vector and an R408 helper phage [17] into Escherichia coli XL1-Blue host cells according to the manufacturer's instructions (Stratagene, La Jolla, CA, U.S.A.). E. coli XL1-Blue was then infected with the rescued phagemid. The infected bacteria were plated out on to Luria broth/ampicillin plates. Ampicillin-resistant colonies were transferred on to nitrocellulose membrane and prepared for colony hybridization [18] . A 20meric oligonucleotide probe (see Figure  1 ) was synthesized according to the nucleotide sequence of a batroxobin cDNA [8] . The The phagemids of positive clones were purified by alkaline lysis of the host cell, followed by equilibrium centrifugation in a CsCI/ethidium-bromide gradient [18] . The nucleotide sequence of the cDNA insert was determined by the dideoxy method using the 'walking primer' strategy ( Figure 2) . § To whom correspondence should be addressed. The nucleotide sequence reported in Figure 3 will appear in the GenBank Database under accession no. L07308. (Figure 2) . In this open reading frame, the translation-initiation site is assigned to the first methionine codon at nucleotides 178-180, which is followed by an uninterrupted coding region, which putatively codes for 258 amino-acid residues ( Figure 3) . The 3' non-coding region contained a poly(A)+ sequence and a putative polyadenylation signal sequence AATAAA (nucleotides 1519-1524), which was located at a site 14 nucleotides upstream from the poly(A)+ sequence ( Figure 3 ). Two putative glycosylation sites, Asn-Xaa-Thr, were located at amino-acid residues 148-150 and 229-231. Ancrod is known to be a glycoprotein [20] .
Amino-acid sequence analysis
The amino-acid sequence deduced from the coding region of the Figure 3 Nucleotide sequence of the ancrod cONA J-5 and the predicted amino-acid sequence of the ancrod precursor protein
The nucleotide residues are numbered on the left and the amino-acid residues are numbered on the right. The amino-acid numbering starts at the N-terminal amino acid, valine of ancrod. The putative pre-peptide and pro-peptide consist of amino acid residues -24 to -7 and -6 to -1 respectively. Arrows indicate predicted cleavage sites. Asterisks indicate putative aminoacid residues that are involved in catalytic action. The putative glycosylation sites are shown in boxes and the polyadenylation-signal sequence, AATAAA, is underlined.
J-5 cDNA (Figure 3 ) was compared with that of the batroxobin precursor (see Figure 4) 
ancrod is valine [20] . The hydrophilic peptide (amino acids -6 to -1) is presumably a zymogen peptide. Figure 4 also shows a high sequence similarity between ancrod and other mature serine proteases [9, 22, 23] . Based on sequence similarity, we could deduce the catalytic amino-acid residues to be His43, Asp88 and Ser'812 ( Figure 4 ). The location of Asp176 at a position equivalent to the bottom of the substrate-binding pocket is consistent with the fact that ancrod cleaves a fibrinopeptide A fragment from fibrinogen after the positively charged arginine residue [13] .
Ancrod contains 13 cysteine residues. Based on comparison of the aligned sequences of batroxobin, flavoxobin and trypsin, six possible disulphide bridges appear to be Cys7_CysI41, Cys28-Cys44, Cys78_Cys232, Cys120_Cys188, Cys152_Cyst67 and
The existence of a free cysteine (Cys180), which changes the common sequence surrounding the active site Ser182 from GlyAsp-Ser-Gly-Gly-Pro to Cys-Asp-Ser-Gly-Gly-Pro, is unusual for a serine protease. To ensure that amino-acid residues unique to ancrod (such as Cys180, Lys42, Argt74) found in the sequence alignment ( Figure 4) were not artefacts derived from the cDNA cloning process, an independent clone J-2 was also sequenced. The sequence of J-2 was consistent with that of the J-5 clone. The replacement of Gly'80 by a cysteine residue in the common sequence around the serine residue of the active site does not seem to decrease the thrombin-like proteolytic activity of ancrod compared with that of batroxobin [8] .
Finally, we speculate that ancrod may also possess a cysteine protease-like activity. Cysteine proteases share some similarities of reaction mechanism with serine proteases [26] , but they are generally active in a higher pH range. The -SH group of a free cysteine residue plays a role that is similar to that of the -OH group of the active-site serine. Cys180, which is located close to the catalytic cave, may be coupled with His43, as generally occurs in cysteine proteases to cleave peptide-bonds.
We thank Dr. Ming-Yi Liau for providing us with venom glands. We also thank Dr. Tur-Fu Huang for helpful advice and Dr. Kong-Bung Choo for critical reading of the manuscript. This work was supported by grant NSC 82-041 8-B075-01 6-BC from the National Science Council of the Republic of China. cDNA clone J-5 does encode for ancrod, which is also a thrombinlike serine protease. Moreover, a 93 % sequence identity between the first 30 amino-acid residues of the N-termini has allowed us to predict that ancrod is also synthesized as a pre-zymogen before maturation, as is batroxobin and other secretory serine proteases [8, [22] [23] [24] . The precursor peptide includes a signal peptide (pre-peptide) and a zymogen peptide (pro-peptide). It is known that signal peptides generally contain a region that is rich in hydrophobic amino-acid residues with large side-chains, and terminate in a residue having a small side-chain (Ala, Ser, or Gly) [25] . Therefore, we predict that a possible site for the cleavage of the signal peptide in the precursor is present after the Ala residue at position -7 (that is, the signal peptide covers the sequence from amino acids -24 to -7; Figure 3 ). The zymogen peptide is known to contain a region that is rich in hydrophilic aminoacid residues [8, 22, 23] and the first N-terminal amino acid of
